| | | | Index Performance | | Index | Sensex | Nifty | | Open | 8,793.89 | 2,716.05 | | High | 8,955.73 | 2,781.95 | | Low | 8,697.46 | 2,701.95 | | Today's Cls | 8,943.54 | 2,777.25 | | Prev Cls | 8,756.61 | 2,719.25 | | Change | 186.93 | 58.00 | | % Change | 2.13 | 2.13 | | | | Market Indicators | | Top Movers (Group A) | | Company | Price
(Rs) | %
chg | | Gainers | | Akruti City | 1404.55 | 19.50 | | Jet Airways | 149.20 | 17.16 | | RNRL | 44.15 | 16.03 | | Essar Oil | 72.85 | 14.72 | | TTML | 24.45 | 14.25 | | Losers | | Tata Tea | 531.05 | -3.21 | | Everest Kanto | 91.40 | -2.61 | | Apollo Hospitals | 370.65 | -2.38 | | Rei Agro | 47.95 | -2.14 | | Sun Pharma | 1,000.85 | -2.05 | | | Market Statistics | | - | BSE | NSE | | Advances | 1,611 | 876 | | Declines | 847 | 310 | | Unchanged | 87 | 50 | | Volume(Nos) | 30.37cr | 62.78cr | | | | | | Market Commentary | | | Sensex above 8900 | | Despite substantial volatility, Sensex continues its upward momentum ending firm above 8900 on late buying in realty and oil & gas stocks. | | The market continued to scale up and closed firm above 8900 levels. Exhibiting a choppy trend in early trades, Sensex gyrated over 100 points after the opening | 
| | | bell and slipped below 8700 mark on sustained selling pressure to touch the day's low of 8697. Recovery started thereafter and the market rebounded into the positive territory in afternoon. Substantial buying in JP Associates, Mahindra & Mahindra, Ranbaxy Laboratories, Reliance Communications, DLF and ICICI Bank saw Sensex notch up significant gains in late trades and touch a new intra-day high of 8956. Sensex wrapped the session 187 points higher at 8944, while the 50-stock Nifty gained 58 points to close at 2777.
Market breadth, the number of advancing and declining stocks, was positive for the day. Of the 2,545 stocks traded on BSE, 1,611 stocks advanced whereas 847 stocks declined. Eighty seven stocks ended unchanged. All the 13 sectoral indices posted gains for the day. BSE Realty flared 5.35% up and BSE Oil gained 3.44%. Other sectoral indices were up 1-2% each. BSE HC and BSE IT ended in the positive territory with marginal gains.
Recovery in the market was led by JP Associates, which shot up by 8.96% at Rs77.25. Among the other major gainers, Mahindra & Mahindra advanced by 8.48% at Rs374.05, Ranbaxy Laboratories moved up by 6.82% at Rs147.95, Reliance Industries added 3.45% at Rs1,327, DLF scaled 6.16% at Rs161.95 and ICICI Bank jumped 4.52% at Rs322.65. Select index stocks witnessed selling pressure. Sun Pharmaceutical Industries dropped 2.05% at Rs1,000.85. Maruti Suzuki India fell 1.90% at Rs698.85, Grasim Industries declined by 1.03% at Rs1477.90, Infosys Technologies lost 0.62% at Rs1,288.25 and Reliance Infrastructure slipped 0.41% at Rs464.75.
Over 2.09 crore shares of Reliance Natural Resources Ltd (RNRL) changed hands on BSE followed by Unitech (1.38 crore shares), Pennar Industries (1.32 crore shares), Satyam Computer Services (1.20 crore shares) and Suzlon Energy (97 lakh shares). | | | | | | | | European Indices at 16:00 IST on 16-03-2009 | | | | Index | Level | Change (pts) | Change (%) | | FTSE 100 Index | 3835.81 | 82.13 | 2.19 | | CAC 40 Index | 2775.29 | 69.66 | 2.57 | | DAX INDEX | 4052.04 | 98.44 | 2.48 | | | | | | | | | | | Asian Indices at close on 16-03-2009 | | | | Index | Level | Change (pts) | Change (%) | | Nikkei 225 | 7704.15 | 134.87 | 1.78 | | Hang Seng Index | 12976.71 | 450.91 | 3.60 | | Kospi Index | 1125.46 | -0.57 | -0.05 | | Straits Times Index | 1586.32 | 8.80 | 0.56 | | Jakarta Composite Index | 1324.84 | -2.59 | -0.20 | | | | | | | | To know more about our products and services, click here. | | | | | | | “This document has been prepared by Sharekhan Ltd. This Document is subject to changes without prior notice and is intended only for the person or entity to which it is addressed to and may contain confidential and/or privileged material and is not for any type of circulation. Any review, retransmission, or any other use is prohibited. Kindly note that this document does not constitute an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction.
Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. SHAREKHAN will not treat recipients as customers by virtue of their receiving this report.
The information contained herein is from publicly available data or other sources believed to be reliable. While we would endeavour to update the information herein on reasonable basis, SHAREKHAN, its subsidiaries and associated companies, their directors and employees (“SHAREKHAN and affiliates”) are under no obligation to update or keep the information current. Also, there may be regulatory, compliance, or other reasons that may prevent SHAREKHAN and affiliates from doing so. We do not represent that information contained herein is accurate or complete and it should not be relied upon as such. This document is prepared for assistance only and is not intended to be and must not alone betaken as the basis for an investment decision. The user assumes the entire risk of any use made of this information. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. We do not undertake to advise you as to any change of our views. Affiliates of Sharekhan may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report.
This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject SHAREKHAN and affiliates to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction.
SHAREKHAN & affiliates may have used the information set forth herein before publication and may have positions in, may from time to time purchase or sell or may be materially interested in any of the securities mentioned or related securities. SHAREKHAN may from time to time solicit from, or perform investment banking, or other services for, any company mentioned herein. Without limiting any of the foregoing, in no event shall SHAREKHAN, any of its affiliates or any third party involved in, or related to, computing or compiling the information have any liability for any damages of any kind. Any comments or statements made herein are those of the analyst and do not necessarily reflect those of SHAREKHAN.” | To unsubscribe write to myaccount@sharekhan.com | |
